Skip to main content
SpringerLink
Log in

Hemodialysis effects on phenytoin pharmacokinetics

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Liponi DF, Winter ME, Tozer TN (1984) Renal function and therapeutic concentrations of phenytoin. Neurology 34(3):395–7

    Article  CAS  PubMed  Google Scholar 

  2. Peterson GM, McLean S, von Witt RJ, Millingen KS (1985) Audit of a monitoring service for free phenytoin. Br J Clin Pharmacol 19(5):693–7

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Frenchie D, Bastani B (1998) Significant removal of phenytoin during high flux dialysis with cellulose triacetate dialyzer. Nephrol Dial Transplant 13(3):817–8

    Article  CAS  PubMed  Google Scholar 

  4. Adler DS, Martin E, Gambertoglio JG, Tozer TN, Spire JP (1975) Hemodialysis of phenytoin in a uremic patient. Clin Pharmacol Ther 18(1):65–9

    CAS  PubMed  Google Scholar 

  5. Dromgoole SH (1973) The effect of haemodialysis on the binding capacity of albumin. Clin Chim Acta 46(4):269–72

    Article  CAS  PubMed  Google Scholar 

  6. Dasgupta A, Abu-Alfa A (1992) Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uremia treated with hemodialysis. Role of uremic compounds. Am J Clin Pathol 98(1):19–25

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Néphrologie, Hôpital Maisonneuve-Rosemont, Département de Médecine, Université de Montréal, Montréal, QC, Canada

    Sarah Bezzaoucha, Amine Merghoub, Caroline Lamarche, Vincent Pichette, Jean-Philippe Lafrance, Louis-Philippe Laurin, Michel Vallée, Robert Robitaille, Martine Leblanc & Robert Bell

  2. Nephrology, Department of Medicine, Hôpital Maisonneuve-Rosemont, 5415 Boulevard de l’Assomption, Montréal, Québec, Canada, H1T 2M4

    Robert Bell

Authors
  1. Sarah Bezzaoucha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amine Merghoub
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Caroline Lamarche
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vincent Pichette
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jean-Philippe Lafrance
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Louis-Philippe Laurin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michel Vallée
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Robert Robitaille
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Martine Leblanc
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Robert Bell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert Bell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bezzaoucha, S., Merghoub, A., Lamarche, C. et al. Hemodialysis effects on phenytoin pharmacokinetics. Eur J Clin Pharmacol 70, 499–500 (2014). https://doi.org/10.1007/s00228-013-1628-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-013-1628-z

Keywords

Search

Navigation